p64血流导向支架血管内治疗颅内动脉瘤:35例患者41个颅内动脉瘤的中期结果
回顾性分析两家机构2015年1月至2016年2月接受p64血流导向装置治疗的颅内动脉瘤患者,35例患者41个动脉瘤纳入分析,35例中2例(5.7%)出现短暂神经功能障碍,无永久性致残或死亡;动脉瘤完全闭塞率在3、6、12个月分别为20/30(66.6%)、18/27(66.6%)、24/28(85.7%),支架内狭窄9/29例(31%),随时间逐渐改善。作者认为在该小样本病例系列中p64血流导向支架用于颅内动脉瘤血管内治疗似乎安全有效。
要点
- 12个月随访动脉瘤完全闭塞率为24/28(85.7%),3个月和6个月均为66.6%。
- 短暂神经功能障碍发生率为2/35(5.7%),无永久性致残或死亡。
- 支架内狭窄见于9/29例(31%),其中中度4/29(13.7%)、轻度5/29(17.2%),随访中逐渐改善。
核心结论
- 作者认为在该小样本病例系列中,p64血流导向支架用于颅内动脉瘤血管内治疗似乎安全有效,观察到较高的闭塞率和较低的并发症率。
研究设计与样本
- 回顾性研究,在两家机构前瞻性维护的数据库中识别2015年1月至2016年2月接受p64血流导向装置治疗的患者,最终纳入35例患者41个颅内动脉瘤;影像随访包括3、6、12个月数字减影血管造影(DSA)及12个月磁共振血管造影(MRA)。
关键影像表现/征象
- 所有动脉瘤均为囊状且未破裂,中位动脉瘤大小6.2 mm,平均瘤颈3.4 mm。
- 支架内狭窄在随访中逐渐改善,6个月和12个月时仅见轻度狭窄。
诊断标准与关键数值
- 动脉瘤完全闭塞率:3个月20/30(66.6%)、6个月18/27(66.6%)、12个月24/28(85.7%)。
- 短暂神经功能障碍2/35(5.7%),包括1例迟发性血栓栓塞并发症;无永久性致残或死亡。
- 支架内狭窄9/29例(31%),其中中度4/29(13.7%)、轻度5/29(17.2%)。
- 支架安全释放失败7/48个动脉瘤(15%),失败病例被排除。
临床应用与阅片要点
- 作者认为p64血流导向支架用于颅内动脉瘤血管内治疗似乎安全有效,观察到较高闭塞率和较低并发症率。
- 原文未据此给出具体阅片或报告推荐。
局限性
- 原文自述为小样本病例系列(small case series)。
- 原文为回顾性识别病例(retrospectively identified)。
- 原文结论使用「appears」提示结果需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
INTRODUCTION: The p64 flow diverter (FD) device is a fully resheathable and detachable stent dedicated for endovascular treatment (EVT) of intracranial aneurysms (IAs). We report our mid-term experience with this device.
METHODS: Between January 2015 and February 2016, we retrospectively identified, in our prospectively maintained database, all patients treated with p64 FDs in two institutions. Independent clinical follow-up was performed by a vascular neurologist. Imaging follow-up included a digitalized subtraction angiography (DSA) at 3, 6, and 12 months and a magnetic resonance angiography (MRA) at 12 months.
RESULTS: Thirty-nine patients (22 women/17 men; median age 54 years) with 48 IAs (median aneurysm size 6.2 mm; mean neck size 3.4 mm) were identified. All IAs were saccular and unruptured. Failure of safe stent delivery occurred in 15% of cases (7/48 IAs) which were excluded. Transient neurological morbidity occurred in 2/35 patients (5.7%) including one delayed thromboembolic complication. No permanent morbidity or mortality was encountered. Complete aneurysmal occlusion at 3, 6, and 12 months was 20/30 (66.6%), 18/27 (66.6%), and 24/28 (85.7%), respectively. Intra-stent stenosis was observed in 9/29 patients (31%) and classified as moderate in 4/29 (13.7%) and mild in 5/29 patients (17.2%). These stenoses gradually improved over time, with only mild stenoses being identified at 6 months and at 12 months.
CONCLUSION: In our small case series, the p64 FD stent appears safe and effective for EVT of IAs. A high occlusion rate and a low morbidity rate were observed.
引用
- Morais R, Mine B, Bruyère PJ, et al. Endovascular treatment of intracranial aneurysms with the p64 flow diverter stent: mid-term results in 35 patients with 41 intracranial aneurysms. Neuroradiology. 2017. PMID: 28236050. doi:10.1007/s00234-017-1786-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。